China Everbright Limited (CEL), a cross-border investment and asset management firm, has announced the first close of its third healthcare fund after securing RMB 800 million ($115.2 million) in commitments from various investors.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
